A Phase II proof of concept study has shown that one of Argenx’ antibodies is effective in treating the neuromuscular disease myasthenia gravis.
Argenx has released the results from a Phase II trial with ARGX-113 (efgartigimod), in which the antibody therapy has proved to provide a significant improvement in patients with generalized myasthenia gravis, a form of the disease that affects the strength of multiple muscles simultaneously. Argenx’ stock on Euronext Brussels is up by 24% a few hours after it opened this
Myasthenia Gravis Symptoms,ID Bracelets, Discussions ,Books, News, Videos and Links to Resources
Sunday, December 17, 2017
Thursday, November 16, 2017
Myasthenia Gravis Symptoms Could Be Relieved By Cognitive Behavioral Therapy
Cognitive Behavioral Therapy (CBT) should be considered as a first-line treatment for myasthenia gravis (MG) patients who also suffer from anxiety, depression, or insomnia disorders, a new study urges.
The study, “Cognitive-Behavioral Therapy for Psychiatric Comorbidity in a Case of Muscle-Specific Kinase–Positive Myasthenia Gravis,” appeared in the journal The Primary Care Companion for CNS Disorders.
MG patients frequently have depression and anxiety. Medications usually help, though some patients suffer adverse events. CBT, a type of psychotherapy, can
Tuesday, November 14, 2017
Relatives Of Myasthenia Gravis Patients Have Higher Risk Of Developing The Disease
Researchers in Taiwan have found that first-degree relatives of individuals with myasthenia gravis have a higher risk of developing the disease. The risk is greater for patients’ siblings, the study found.
The study, “Familial aggregation of myasthenia gravis in affected families: a population-based study,” appeared in the journal Clinical Epidemiology.
The study, “Familial aggregation of myasthenia gravis in affected families: a population-based study,” appeared in the journal Clinical Epidemiology.
Labels:
AUTOIMMUNE DISEASES,
ENVIRONMENTAL FACTORS,
FAMILIAL AGGREGATION,
FIRST-DEGREE RELATIVES,
GENETIC FACTORS,
RISK
Wednesday, October 18, 2017
MG Respiratory Failure Requires Specific Treatments in the ER, Review Contends
Myasthenic crisis is a common complication in patients with myasthenia gravis (MG), marked by exacerbation of MG symptoms and respiratory failure. But with the rarity of MG, and its similarity to a range of other neuromuscular diseases, proper detection and treatment might fail, researchers argue.
Wednesday, September 27, 2017
It Wasn't A Stroke But All The Signs Pointed That Way
“Mom?” the middle-aged man asked. He recognized the voice, but the words were muffled and strange. I’ll be right over, he said into the phone. The 15-minute drive from his small Connecticut town to his mother’s seemed to last forever. Had she had a stroke? She was 94, and though she’d always been
Friday, September 8, 2017
Vitamin D3 Deficiency Linked To Myasthenia Gravis - Study Confirms
![]() |
Vitamin D From Fish Oil |
Abstract:
Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disorder. Vitamin D has important roles both in the autoimmune response and in skeletal muscles. We determined the levels of 25-hydroxy vitamin D [25(OH)D] in patients with MG and in healthy subjects to determine whether vitamin D deficiency is present in MG and whether vitamin D supplementation has beneficial effects on fatigue.
Dentistry and Myasthenia Gravis - What You and Your Dentist Need to Know
Dentistry and Myasthenia Gravis
The following article is courtesy of the Myasthenia Gravis Association of Western Pennsylvania
Dentistry can be a part of normal health care for the myasthenic and should not be feared or avoided. The objective of this article is to give both the dentist and the myasthenic a basis for understanding and communication that will result in
The following article is courtesy of the Myasthenia Gravis Association of Western Pennsylvania
Dentistry can be a part of normal health care for the myasthenic and should not be feared or avoided. The objective of this article is to give both the dentist and the myasthenic a basis for understanding and communication that will result in
Friday, June 30, 2017
Outcomes After Major Surgery For Patients With Myasthenia Gravis
A couple of months ago I came close to having a total knee replacement but decided against it because of my myasthenia gravis. I just thought it was too risky. My symptoms are pretty much under control and I count myself among those MG patients that have a "relatively normal lifestyle." But I've worked hard to keep it under control and I didn't want to risk a setback. There are plenty of stories on the internet about MG patients having major surgery that worked out well and others that didn't. I just didn't want to take the chance.
Friday, June 16, 2017
Transfusions, Surgery And Medication: Young Girl With Myasthenia Gravis Is Symptom Free
![]() |
Ashley Earl-Goulet, pictured with mum Judith, has has recovered thanks to more than 600 blood donations |
Ashley Earl-Goulet, 14, is the only child in the South Island and one of just a handful in New Zealand with myasthenia gravis, a long-term neuromuscular disease which weakens muscles – most commonly in the eyes and face.
Ashley's treatment included a blood "product" nick-named "go go juice" by health workers
Wednesday, June 14, 2017
Town Supervisor Steps Down After Fighting Myasthenia Gravis For Two Years
Hornellsville supervisor will leave post at end of year
ARKPORT — Fighting myasthenia gravis for the past two years has been a chore for Ken Isaman. After 28 years as a Hornellsville councilman and supervisor, he will say goodbye to town government at the end of 2017.
The 69-year-old Republican, who also served for 12 years on the Steuben County Legislature, told the Hornellsville Town Board Tuesday night that he will not be a candidate for reelection in the fall. Isaman has been battling health issues
ARKPORT — Fighting myasthenia gravis for the past two years has been a chore for Ken Isaman. After 28 years as a Hornellsville councilman and supervisor, he will say goodbye to town government at the end of 2017.
The 69-year-old Republican, who also served for 12 years on the Steuben County Legislature, told the Hornellsville Town Board Tuesday night that he will not be a candidate for reelection in the fall. Isaman has been battling health issues
Tuesday, June 13, 2017
Scientists Make First Crystal Model Of Myasthenia Gravis
As a molecular biologist, Kaori Noridomi gets an up-close view of the targets of her investigations. But when she began studying the molecular structures of a rarely diagnosed autoimmune disorder, myasthenia gravis, she decided to step out of the lab for a better view.
Noridomi said she thought she needed to know more than what she saw on a microscope and decided she should meet patients who have myasthenia gravis. She went so far
Noridomi said she thought she needed to know more than what she saw on a microscope and decided she should meet patients who have myasthenia gravis. She went so far
Sunday, May 14, 2017
Prolonged Asystole (Flat Line) In MG Patient Induced by Pyridostigmine. Successfully Treated with Hyoscyamine
Dr. Mohammad Saud Khan
Reversible acetylcholinesterase inhibitors are used as first-line treatment for myasthenia gravis (MG).
They improve symptoms by increasing concentration of acetylcholine at the neuromuscular junction and stimulating nicotinic receptors. Serious bradyarrhythmias can occur from muscarinic stimulation in heart, which in rare cases may progress to asystole (Flat Lining on ECG monitor).
Reversible acetylcholinesterase inhibitors are used as first-line treatment for myasthenia gravis (MG).
They improve symptoms by increasing concentration of acetylcholine at the neuromuscular junction and stimulating nicotinic receptors. Serious bradyarrhythmias can occur from muscarinic stimulation in heart, which in rare cases may progress to asystole (Flat Lining on ECG monitor).
Friday, April 7, 2017
Together - For Better or Worse
CLOVIS NEWS
APRIL 06, 2017 12:30 PM
For better, for worse
BY JANESSA TYLER
Senior Living Staff Writer
It has been nearly 15 years since Dwight Harder was diagnosed with Parkinson’s disease — a degenerative disorder of the central nervous system.
With April designated as National Parkinson’s Awareness Month, Dwight hopes his story will be inspirational and, most importantly, educational for people who face chronic illnesses and diseases.
Tuesday, April 4, 2017
MG Walk Welcomed By Mayor Of Brook Run
Mayor Denis Shortal supported the 5th annual Myasthenia Gravis Walk last month at the Brook Run Park in Dunwoody. Mayor Shortal became the first mayor to open a Myasthenia Gravis Walk. The local Myasthenia Gravis chapter was delighted to have support from mayor and look forward to seeing him future events.
Tuesday, February 28, 2017
Positive Outlook Helps Young Woman With Generalized Myasthenia Gravis
Johannesburg – While she calls herself a mother of three “fur-kids”, Megan Hunter’s biggest dream is to have a baby.
“I want to be strong enough to be able to fall pregnant and have a baby. That really is my biggest wish and my heart aches for one.”
The 28-year-old is one in 5 000 people with Myasthenia Gravis: an extremely rare neuromuscular, autoimmune disease that affects all her muscles.
“I want to be strong enough to be able to fall pregnant and have a baby. That really is my biggest wish and my heart aches for one.”
The 28-year-old is one in 5 000 people with Myasthenia Gravis: an extremely rare neuromuscular, autoimmune disease that affects all her muscles.
Thursday, February 2, 2017
After Massive Dose of Vitamin D Myasthenia Gravis Patients Goes Into Remission
By Flávio Adsuara Cadegiani | Published at NCBI |
Vitamin D has been shown to be related to autoimmune diseases, such as multiple sclerosis and psoriasis. Correlations have been reported between vitamin D levels and prevalence and severity of other autoimmune disorders, and also between vitamin D therapy and disease improvement and remission.
Below is a case report of a patient with severe and refractory myasthenia gravis (MG) who followed a “high-dose vitamin D treatment”, a massive-dose treatment (80 000 to 120 000 IU/day) promoted by a medical center in Brazil (but still not proven), and she had her first complete remission after this type of treatment with increased vitamin D serum levels (400 to 700 ng/mL)
Vitamin D has been shown to be related to autoimmune diseases, such as multiple sclerosis and psoriasis. Correlations have been reported between vitamin D levels and prevalence and severity of other autoimmune disorders, and also between vitamin D therapy and disease improvement and remission.
Below is a case report of a patient with severe and refractory myasthenia gravis (MG) who followed a “high-dose vitamin D treatment”, a massive-dose treatment (80 000 to 120 000 IU/day) promoted by a medical center in Brazil (but still not proven), and she had her first complete remission after this type of treatment with increased vitamin D serum levels (400 to 700 ng/mL)
Labels:
Autoimmune,
Experimental,
Myasthenia Gravis,
vitamin D
Subscribe to:
Posts (Atom)